Mad in America

JANUARY 1, 2024

In this blog, he addresses the scientific literature on antidepressant efficacy and FDA approval. S ome of the following studies appeared in my book Antidepressants: Science, Magic or Marketing , 1 and in the next section, I will report on some of the more recent depression treatment outcome studies.

Healthcare 84

Healthcare Self-awareness Genetics and mental health Cognitive Behavioral Therapy 84

Mad in America

APRIL 27, 2024

This was a story of a great medical advance, and the announced results from the STAR*D trial, heralded by the NIMH as the “largest and longest study ever done to evaluate depression treatment,” fit into that story of medical progress, for it told of 70% of depressed patients becoming “symptom free” after repeated treatments with antidepressants.

Self-awareness 145

Self-awareness Depression treatment 145

Mad in America

JANUARY 3, 2024

Five months after Prozac came to market, the NIMH launched a “Depression Awareness, Recognition and Treatment” campaign. The purpose of DART was “to change public attitudes so that there is greater acceptance of depression as a disorder rather than a weakness.” The major media has remained silent.

Neurotransmitters and mental health 145

Neurotransmitters and mental health Hospitality Education Self-awareness 145